Abstract: A method of treating a disease in a mammal by administering a therapeutic effective amount of an amphoteric zwitterion compound as an active ingredient. A pharmaceutical composition which comprises an amphoteric zwitterionic compound as an active ingredient in combination with a carrier and other adjunctive pharmaceutical agents.
Type:
Grant
Filed:
November 2, 1998
Date of Patent:
June 6, 2000
Assignee:
T. Ronald Theodore
Inventors:
T. Ronald Theodore, Roscoe L. Van Zandt
Abstract: A substituted piperazine zwitterion composition containing, for example, as an active ingredient, HEPES (N-2 Hydroxyethylpiperazine-N'-2 Ethane Sulfonic Acid), and method useful for treatment of cancer, autoimmune, arthritis and other mammalian diseases.
Type:
Grant
Filed:
February 13, 1996
Date of Patent:
February 10, 1998
Assignee:
T. Ronald Theodore
Inventors:
T. Ronald Theodore, Roscoe L. Van Zandt